An optical device including a partial or incomplete optic configured operatively as an add-on (e.g., supplemental lens/optic) for an (existing) optical element or system, the partial or incomplete optic having an active area configured in relation to the optical element or system such that the partial or incomplete optic controls or changes foci of light incident upon or provided to the active area, but does not control or change foci of light bypassing optically relevant portions of the partial or incomplete optic, and associated methods for enhancing vision.

An implantable device for supporting an artificial intraocular lens in an eye having an anterior segment of a capsular bag, an iris, and a sclera. The device includes a posterior platform having an anterior-facing surface and an inner wall defining, at least in part, a central aperture. When the device is implanted in the eye, light passes through the intraocular lens and the central aperture of the posterior platform towards the retina. The device includes at least one awning positioned over the anterior-facing surface of the posterior platform forming at least one recess anterior to the posterior platform. The device is configured to be deployed in the eye posterior of the iris so that no portion of the device rests in contact with the sclera after implantation. Related tools, systems, and methods are provided.

Various embodiments are described herein for an ocular device implantable in a user's eye and which has an adjustable optical element for varying one or more optical properties for the eye such as, but not limited to, providing a dynamically adjustable aperture stop to control the amount of incoming light, filtering incoming light, polarizing incoming light, and/or varying a depth of field for the eye.

Various embodiments are described herein for an ocular device implantable in a user's eye and which has an adjustable optical element for varying one or more optical properties for the eye such as, but not limited to, providing a dynamically adjustable aperture stop to control the amount of incoming light, filtering incoming light, polarizing incoming light, and/or varying a depth of field for the eye.

A lens for use in an intraocular lens system for treating age-related macular degeneration (AMD), the lens including an anterior surface, a posterior surface, and a plurality of haptics configured to align the anterior light-converging intraocular lens with an optical axis of the eye. The plurality of haptics may have a symmetrical design and comprising ciliary-sulcus-engaging surfaces configure to position the lens within in a ciliary sulcus of an eye. At least one of the anterior surface and the posterior surface may be rendered as aspherical surfaces selected to induce spherical aberration while minimizing optical aberration and thereby provide for a continuum of retinal images to be focused at an area macula of a retina of the eye between two retinal eccentricities.

Implantable corneal and intraocular implants such as a mask are provided. The mask can improve the vision of a patient, such as by being configured to increase the depth of focus of an eye of a patient. The mask can include an aperture configured to transmit along an optical axis substantially all visible incident light. The mask can further include a transition portion that surrounds at least a portion of the aperture. This portion can be configured to switch from one level of opacity to another level of opacity through the use of a controllably variable absorbance feature such as a switchable photochromic chromophore within a polymer matrix.

Exemplary light control devices and methods provide a regional variation of visual information and sampling (“V-VIS”) of an ocular field of view that improves or stabilizes vision, ameliorates a visual symptom, reduces the rate of vision loss, or reduces the progression of an ophthalmic or neurologic condition, disease, injury or disorder. The V-VIS devices and methods generate a moving aperture effect anterior to a retina that samples and delivers to the retina environmental light from an ocular field of view at a sampling rate between 50 hertz and 50 kilohertz. Certain of these V-VIS devices and methods may be combined with augmented or virtual reality, vision measurement, vision monitoring, or other therapies including, but not limited to, pharmacological, gene, retinal replacement and stem cell therapies.

Ophthalmic implants, their methods of use and manufacture. The implants may include a transparent optic portion and a peripheral non-optic portion coupled to the optic portion. The transparent optic portion may be made of a transparent optic material adapted to allow visible light to pass therethrough, and the peripheral non-optic portion may be made of a light absorbing material adapted to absorb visible light.

Exemplary light control devices and methods provide a regional variation of visual information and sampling (“V-VIS”) of an ocular field of view that improves or stabilizes vision, ameliorates a visual symptom, reduces the rate of vision loss, or reduces the progression of an ophthalmic or neurologic condition, disease, injury or disorder. The V-VIS devices and methods generate a moving aperture effect anterior to a retina that samples and delivers to the retina environmental light from an ocular field of view at a sampling rate between 50 hertz and 50 kilohertz. Certain of these V-VIS devices and methods may be combined with augmented or virtual reality, vision measurement, vision monitoring, or other therapies including, but not limited to, pharmacological, gene, retinal replacement and stem cell therapies.

A process for reducing the likelihood of or correcting dysphotopsia from intraocular lens implant surgery. The process includes a step of scanning the eye of a patient in need of the intraocular lens implant surgery using a noninvasive echo-locating instrument for obtaining nasal retina information about the eye. Based at least in part from the nasal retina information, a prophylactic measure can be recommended prior to cataract removal surgery, or a corrective measure can be recommended to address the dysphotopsia after the cataract removal surgery. Use of artificial intelligence as part of the process is also contemplated.